|
|
Article: Geron Corporation Reports Stem Cell Therapeutic for Spinal Cord Injury Produces Nerve Growth Factors.
- Article from:
- M2 Presswire
- Article date:
- January 17, 2007
CopyrightCOPYRIGHT 2007 M2 Communications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-17 January 2007-Afternoon Movers: Geron Corporation Reports Stem Cell Therapeutic for Spinal Cord Injury Produces Nerve Growth Factors(C)1994-2007 M2 COMMUNICATIONS LTD
RDATE:17012007
Geron Corporation (NASDAQ:GERN) is developing first-in-class biopharmaceuticals for the treatment of cancer and degenerative diseases, including spinal cord injury, heart failure, diabetes and HIV/AIDS. The company is advancing an anticancer drug and a cancer vaccine that target the enzyme telomerase through multiple clinical trials. Geron is also the world leader in the development of human embryonic stem cell-based therapeutics, with its spinal cord injury ...